Type 1 diabetes and other organ-specific autoimmune diseases often cluster together in human families and in congenic strains of NOD (nonobese diabetic) mice, but the inherited immunoregulatory defects responsible for these diseases are unknown. Here we track the fate of high avidity CD4 T cells recognizing a self-antigen expressed in pancreatic islet β cells using a transgenic mouse model. T cells of identical specificity, recognizing a dominant peptide from the same islet antigen and major histocompatibility complex (MHC)-presenting molecule, were followed on autoimmune susceptible and resistant genetic backgrounds. We show that non-MHC genes from the NOD strain cause a failure to delete these high avidity autoreactive T cells during their development in the thymus, with subsequent spontaneous breakdown of CD4 cell tolerance to the islet antigen, formation of intra-islet germinal centers, and high titre immunoglobulin G1 autoantibody production. In mixed bone marrow chimeric animals, defective thymic deletion was intrinsic to T cells carrying diabetes susceptibility genes. These results demonstrate a primary failure to censor forbidden clones of self-reactive T cells in inherited susceptibility to organ-specific autoimmune disease, and highlight the importance of thymic mechanisms of tolerance in organ-specific tolerance.
Skip Nav Destination
Article navigation
4 November 2002
Article|
October 28 2002
Failure to Censor Forbidden Clones of CD4 T Cells in Autoimmune Diabetes
Sylvie Lesage,
Sylvie Lesage
Australian Cancer Research Foundation Genetics Lab, Medical Genome Centre, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia
Search for other works by this author on:
Suzanne B. Hartley,
Suzanne B. Hartley
Australian Cancer Research Foundation Genetics Lab, Medical Genome Centre, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia
Search for other works by this author on:
Srinivas Akkaraju,
Srinivas Akkaraju
Australian Cancer Research Foundation Genetics Lab, Medical Genome Centre, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia
Search for other works by this author on:
Judith Wilson,
Judith Wilson
Australian Cancer Research Foundation Genetics Lab, Medical Genome Centre, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia
Search for other works by this author on:
Michelle Townsend,
Michelle Townsend
Australian Cancer Research Foundation Genetics Lab, Medical Genome Centre, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia
Search for other works by this author on:
Christopher C. Goodnow
Christopher C. Goodnow
Australian Cancer Research Foundation Genetics Lab, Medical Genome Centre, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia
Search for other works by this author on:
Sylvie Lesage
Australian Cancer Research Foundation Genetics Lab, Medical Genome Centre, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia
Suzanne B. Hartley
Australian Cancer Research Foundation Genetics Lab, Medical Genome Centre, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia
Srinivas Akkaraju
Australian Cancer Research Foundation Genetics Lab, Medical Genome Centre, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia
Judith Wilson
Australian Cancer Research Foundation Genetics Lab, Medical Genome Centre, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia
Michelle Townsend
Australian Cancer Research Foundation Genetics Lab, Medical Genome Centre, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia
Christopher C. Goodnow
Australian Cancer Research Foundation Genetics Lab, Medical Genome Centre, John Curtin School of Medical Research, Australian National University, Canberra ACT 2601, Australia
Address correspondence to Christopher C. Goodnow, Australian Cancer Research Foundation Genetics Laboratory, Medical Genome Centre, John Curtin School of Medical Research, Mills Rd., PO Box 334, The Australian National University Canberra, ACT 2601 Australia. Phone: 61-26125-3621; Fax: 61-2-6125-8512; E-mail: [email protected]
*
Abbreviations used in this paper: HEL, hen egg lysozyme; insHEL, transgenic mice expressing HEL under the rat insulin promoter; NOD, nonobese diabetic.
Received:
May 07 2002
Revision Received:
August 14 2002
Accepted:
September 16 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 196 (9): 1175–1188.
Article history
Received:
May 07 2002
Revision Received:
August 14 2002
Accepted:
September 16 2002
Citation
Sylvie Lesage, Suzanne B. Hartley, Srinivas Akkaraju, Judith Wilson, Michelle Townsend, Christopher C. Goodnow; Failure to Censor Forbidden Clones of CD4 T Cells in Autoimmune Diabetes . J Exp Med 4 November 2002; 196 (9): 1175–1188. doi: https://doi.org/10.1084/jem.20020735
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement